Tenaya Therapeutics (NASDAQ: TNYA)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Tenaya Therapeutics (NASDAQ: TNYA) through any online brokerage.
Other companies in Tenaya Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Graphite Bio (NASDAQ:GRPH) and Impel Pharmaceuticals (NASDAQ:IMPL).
The latest price target for Tenaya Therapeutics (NASDAQ: TNYA) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.30 expecting TNYA to fall to within 12 months (a possible -21.25% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Tenaya Therapeutics (NASDAQ: TNYA) is $5.46 last updated August 11, 2022, 8:00 PM UTC.
The next Tenaya Therapeutics (TNYA) dividend date is projected to be Monday, August 22, 2022.
Tenaya Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Tenaya Therapeutics.
Tenaya Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.